Vector Science and Therapeutics shares rise 2.86% on peptide collaboration, SAFE investment
The TSXV-listed company tied the move to a peptide partnership alongside a SAFE investment in Gary Payton's Scoreboard brand.
TR
By Tom Reyes · Markets Editor
Oct 7 11:32 ETSource: kalkine.ca
The wire
- 01Vector Science and Therapeutics (TSXV:PAIN) stock gained 2.86% after disclosing a peptide collaboration and a SAFE investment in Gary Payton's Scoreboard.
- 02Small-cap peptide developers remain a thin but watched corner of the sector for readers tracking early-stage supply and development deals.
- 03Deal size, the peptides involved and development timelines were not detailed in the report.
From the source
Read at kalkine.caVector Science and Therapeutics Stock Rises 2.86% After Peptide Collaboration and SAFE Investment in Gary Payton's Scoreboard (TSXV:PAIN)
